Latest Operating Expenses News

Tinybeans Group Ltd reported a significant reduction in losses and a 12% rise in subscription revenue for FY25, driven by a strategic pivot away from advertising. The company’s restructuring efforts have improved cash flow and positioned it for sustainable growth.

Netwealth Group Limited reported robust FY25 results, with Funds Under Administration soaring to $112.8 billion and net profit after tax climbing nearly 40%, underpinned by strong operational leverage and strategic investments.

Peter Warren Automotive Holdings reported a steady FY25 underlying profit before tax of $22.3 million, maintaining revenue despite a challenging new car market and declaring a final dividend. The group’s strategic focus on cost control, inventory discipline, and acquisitions underpinned its resilience.

Netwealth Group Limited has reported a stellar FY25 with record funds under administration net flows of $15.8 billion and a 31% rise in EBITDA, underpinned by strong adviser growth and strategic technology investments.

Netwealth Group Limited reported a standout FY2025 with net profit rising nearly 40% and funds under administration climbing 28%, underpinning a 37.5% increase in dividends. Strategic fintech acquisitions and robust governance enhancements position the company for sustained growth.

Megaport Limited delivered a robust FY25 with 20% growth in annual recurring revenue and EBITDA surpassing guidance, setting the stage for continued expansion in FY26.

Redox Limited reported a 9.4% increase in FY25 revenue to $1.244 billion driven by volume growth and strategic acquisitions, while profits declined amid inflationary pressures. The company declared a final dividend of 6.5 cents per share and maintains zero net debt.

Telix Pharmaceuticals reported a robust 63% revenue increase in H1 2025, driven by commercial growth and strategic investments, while advancing key clinical trials and maintaining full-year guidance.

Telix Pharmaceuticals reported a robust 63% increase in revenue to $390.4 million for the first half of 2025, driven by strong Illuccix sales and the acquisition of RLS Radiopharmacies. Despite this growth, the company recorded a net loss of $2.3 million, reflecting increased investments and finance costs.

QuickFee Limited reports a robust 25% revenue increase in FY25 alongside a return to profitability, setting a confident earnings guidance for FY26 backed by its expanding Connect platform.

Charter Hall Group reported a mixed FY25 financial performance, with revenue declining but operating earnings and dividends increasing, highlighting resilience amid challenges.

Redox Limited reported a 9.4% increase in FY25 revenue to $1.244 billion amid challenging global conditions, while profit after tax declined 14.6% to $77.1 million due to margin normalization and rising costs. The company completed three strategic acquisitions and declared a fully franked dividend of 12.5 cents per share.